Vericel (VCEL) Net Cash Flow (2010 - 2026)
Vericel (VCEL) reported Net Cash Flow of $9.2 million for Q1 2026, up 272.21% on a YoY basis from $2.5 million in Q1 2025, and up 3059.16% sequentially from -$311000.0 in Q4 2025.
Vericel (VCEL) Net Cash Flow (2010 - 2026) Analysis & Trends
Vericel (VCEL) has 17 years of Net Cash Flow data on file, last reported at $9.2 million in Q1 2026.
- For the quarter ending Q1 2026, Net Cash Flow rose 272.21% year-over-year to $9.2 million; the trailing twelve-month figure through Mar 2026 stood at $29.6 million (up 230.13% YoY), and the FY2025 full-year result was $15.0 million, up 927.9% from the prior year.
- Net Cash Flow grew to $9.2 million in Q1 2026, from -$311000.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $19.9 million in Q3 2025 to a low of -$16.1 million in Q1 2024.
- A 5-year average of $2.4 million and a median of $3.0 million in 2022 frame the typical range for Net Cash Flow.
- Across the five-year window, Net Cash Flow jumped 2174.18% in 2023 and slumped 249.75% in 2024, its largest moves.
- Tracing VCEL's Net Cash Flow over 5 years: stood at -$14.1 million in 2022, then jumped by 123.36% to $3.3 million in 2023, then surged by 344.75% to $14.7 million in 2024, then tumbled by 102.12% to -$311000.0 in 2025, then soared by 3059.16% to $9.2 million in 2026.
- Business Quant data shows VCEL's Net Cash Flow at $9.2 million in Q1 2026, -$311000.0 in Q4 2025, and $19.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | 9.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.20 Mn |
| Mar 31, 2026 | 9.20 Mn |
| Dec 31, 2025 | -311,000.00 |
| Dec 31, 2025 | -311,000.00 |
| Sep 30, 2025 | 19.87 Mn |
| Sep 30, 2025 | 19.87 Mn |
| Jun 30, 2025 | 827,000.00 |
| Jun 30, 2025 | 827,000.00 |
| Mar 31, 2025 | -5.34 Mn |
| Mar 31, 2025 | -5.34 Mn |
| Dec 31, 2024 | 14.70 Mn |
| Dec 31, 2024 | 14.70 Mn |
| Sep 30, 2024 | -5.50 Mn |
| Sep 30, 2024 | -5.50 Mn |
| Jun 30, 2024 | 5.11 Mn |
| Jun 30, 2024 | 5.11 Mn |
| Mar 31, 2024 | -16.12 Mn |
| Mar 31, 2024 | -16.12 Mn |
| Dec 31, 2023 | 3.31 Mn |
| Dec 31, 2023 | 3.31 Mn |